{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

SURVEY QUESTIONAIRE

An observational, cross-sectional survey to evaluate the management of patients with moderate to severe Allergic Rhinitis & role of Antihistamines in the Indian Setting
  1. What percentage of patients do you see with Moderate to Severe AR in a month? *
    2. Percentage Tick where applicable

    1-10%

    11-30%

    31-40%

    >40%

  2. What are the cardinal signs you observe in your moderate to severe AR patients? *
    3. Signs Tick all applicable

    Nasal congestion

    Sneezing

    Rhinorrhea

    Ocular Symptoms

  3. What percentage of your moderate to severe AR patients suffer with concomitant Asthma? *
    4. Percentage Tick where applicable

    1-10%

    11-30%

    31-40%

    >40%

  4. What are the most common allergens you observe as triggers of moderate to severe AR in your practice? *
    5. Signs Tick all applicable

    mold

    Dust mite

    Pets

    Pollens

  5. Which are the most common allergic comorbidities you observe in your patients with moderate to severe AR? *
  6. Which are the most common systemic comorbidities you observe in your patients with moderate to severe AR? *
  7. Which are the most common investigations you perform in your practice with moderate to severe AR? *
    8. A.
    B.
    C.
    D.
  8. How do you manage your patients with moderate to severe AR? *
    9. Drug class Dosage Form Duration of treatment Follow up
    (Weeks/months)

    Steroids

    Antihistaminic

    Anticholinergic

    Antibiotics

  9. What are the factors determining the choice of drug selection in patients with moderate to severe AR? *
    10. Signs Tick all applicable

    Tolerability

    Duration of action

    Onset of action

    Patient compliance

  10. What is the drug class of choice in managing patients with Moderate to Severe AR? *

  11. Which Antihistamine do you use in moderate to severe AR patients? *
    12. Drug class Dosage Form Duration of treatment Follow up
    (Weeks/months)     		Common Side effects

    Bilastine+Montelukast

    Levocetirizine+ Montelukast

    Fexofenadine Montelukast

    Desloratadine+ Montelukast

  12. What percentage of patients remain uncontrolled with the standard prescribed dose of antihistamine? *
    13. Percentage Tick where applicable

    1-10%

    11-30%

    31-40%

    >40%

  13. How often do you increase the dose of antihistamines and which are the conditions recommended? *
  14. If yes which are the common side effects of various antihistamines you observe in your practice?
  15. What percentage of patients do you prefer Bilastine+Montelukast for moderate to severe Allergic Rhinitis ? *
    16. Type of AR % Use of Bilastine+Montelukast

    Moderate AR

    Severe AR

  16. Which property of Bilastine do you feel adds value to improve patient outcome in Moderate to Severe AR? *
    17. Properties of Bilastine Tick where applicable

    Non-sedative

    No Drug-Drug Interaction

    Rapid onset of action

    Tolerability

    Cardiotoxicity

  17. Do you have any prior experience of using 40 mg of Bilastine in patients with moderate to Severe AR? *

  18. What duration of therapy do you preference in patients with moderate to Severe AR? *
    19. Dose Duration /month/week

    Bilastine 20 mg +Montelukast 10 mg

    Bilastine 40 mg +Montelukast 10 mg

  19. What other indications apart from AR do you feel Montelukast 10mg +Bilastine 40 mg could be of clinical significance? *
  20. As per your clinical experience what is the unmet need to improve patient outcomes in moderate to severe AR cases ? *